DUBLIN--(BUSINESS WIRE)--The "Biosimulation Market Size, Share & Trend Analysis Report By Product (Software, Services), By Application (Drug, Development, Discovery), By End-use, By Region, Vendor Landscape, And Segment Forecasts, 2018 - 2024" report has been added to ResearchAndMarkets.com's offering.
Key Findings
- Software accounted for the largest share of the product segment in 2015 owing to growing adoption in personalized medicine resulting in improved patient outcomes.
- The services segment is expected to exhibit growth at a significant CAGR as a consequence of rising inclination of the big pharmaceutical companies to outsource their biosimulation process so as to reduce the overall cost.
- The drug discovery segment is predicted to witness a lucrative CAGR throughout the forecast period owing to elimination of probable drug failures and prediction of unfavorable drug interactions.
- Drug development accounted for the largest share owing to growing usage of in silico software by major pharmaceutical & biotechnology companies for increased drug efficacy of their existing products by identification and evaluation of optimal synergistic combinations & dosage forms.
Topics Covered
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
Chapter 5. Market Categorization 1: Product Estimates & Trend Analysis
Chapter 6. Market Categorization 2: Application Estimates & Trend Analysis
Chapter 7. Market Categorization 3: End-use Estimates & Trend Analysis
Chapter 8. Market Categorization 4: Regional Estimates & Trend Analysis
Chapter 9. Competitive Landscape
- Certara USA, Inc.
- Simulation Plus, Inc.
- Dassault Systems SA
- Schrodinger, Inc.
- Advanced Chemistry Development, Inc.
- Chemical Computing Group, Inc.
- Physiomics PLC
- Entelos, Inc.
- Rhenovia Pharma Ltd.
- Genedata AG
- Leadscope, Inc.
- Evidera, Inc.
- Insilico Biotechnology AG
- LeadInvent Technologies Pvt. Ltd.
- InhibOx Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/h5zgc5/global?w=4